you're currently located at: you're currently located at: MAIN :: SUMMARIES :: Anti-parkinson agents
Shake it up
Shake it up (woo-hoo!)
--The Cars, "Shake It Up"
Anti-parkinson drugs are used to treat Parkinson disease (PD) and related syndromes ("parkinsonism"; "parkinsonian syndromes", et al).
These terms are broad, encompassing many diseases that all share the component of damage to specific parts of the brain (namely the regions known as the "striatronigral pathway" and "basal ganglia"). So, it makes a lot of sense that all of these parkinsonian disorders share symptoms -- common symptoms are essential (24/7) tremor, intentioned (occurring while aiming the hand to a target) tremor, fatigue/depression, ataxia (difficulty walking), and vagal hyperhidrosis (a type of excessive sweating).
Classic Parkinson disease (PD), the one we hear of most often, strikes people during their late middle age and is of unknown biological cause. A major variant of PD is one that shows up in younger adults (e.g., Michael J. Fox's case).
Unsurprisingly, the "parkinson-" syndromes share similar features with "regular" PD. Somewhat ironically, these parkinsonian syndromes generally have a known cause, ranging from brain infection (encephalitis and the related meningitis) to head trauma to genetic syndromes to what have you. Treatment of patients with antipsychotic agents is also one way that parkinsonism can develop.
In any event, anti-parkinsonian agents may be helpful no matter what the cause of your parkinsonism is.
The crux of effective treatment of the parkinsonian disorders is the stimulation of dopaminergic neurons. Most drugs that are effective in these disorders are "pro-dopaminergic" in some way, shape, or form.
Page last updated 21 March 2008 (Added tidbit on MAOI treatment)
The above was just a summary. For all intents and purposes, I pulled the above information out of my arse without really looking at authoritative sources. I'll be looking more seriously into these topics with the use of published sources (and of course, citations here) when I get the opportunity to write up the full version of this topic.